First Time Loading...

MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 7.5 USD 2.6% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

MDXG Price Targets Summary
MiMedx Group Inc

Wall Street analysts forecast MDXG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXG is 12.75 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

Lowest
Price Target
11.11 USD
48% Upside
Average
Price Target
12.75 USD
70% Upside
Highest
Price Target
14.7 USD
96% Upside

MDXG Last Price Targets
MiMedx Group Inc

The latest public price target was made on Apr 29, 2024 by Brooks O'Neil from Lake Street , who expects MDXG stock to rise by 60% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Brooks O'Neil
Lake Street
12 USD
Upside 60%
4 days ago
Apr 29, 2024
Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street
TheFly
Brooks O'Neil
Lake Street
Price Target 12 USD
Upside/Downside 60%
View Source
MiMedx Group Inc Competitors:
Price Targets
NTRA
Natera Inc
13% Upside
BIOG B
Biogaia AB
35% Upside
LVTX
LAVA Therapeutics NV
124% Upside
BPMC
Blueprint Medicines Corp
7% Downside
SWTX
SpringWorks Therapeutics Inc
56% Upside
688520
Sinocelltech Group Ltd
41% Upside
87S
Roivant Sciences Ltd
45% Upside
IVA
Inventiva SA
315% Upside

Revenue
Forecast

Revenue Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's revenue is 7%. The projected CAGR for the next 3 years is 13%.

7%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's operating income is 7%. The projected CAGR for the next 3 years is 27%.

7%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-56%
Average Miss

Net Income
Forecast

Net Income Estimate
MiMedx Group Inc

For the last 8 years the compound annual growth rate for MiMedx Group Inc's net income is 6%. The projected CAGR for the next 3 years is 19%.

6%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDXG's stock price target?
Price Target
12.75 USD

According to Wall Street analysts, the average 1-year price target for MDXG is 12.75 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

What is MiMedx Group Inc's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's revenue is 7%. The projected CAGR for the next 3 years is 13%.

What is MiMedx Group Inc's Operating Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's operating income is 7%. The projected CAGR for the next 3 years is 27%.

What is MiMedx Group Inc's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for MiMedx Group Inc's net income is 6%. The projected CAGR for the next 3 years is 19%.